The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Alopecia treatment drugs.

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

110 innovations will shape the pharmaceutical industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. Adeno-associated virus vectors, alcohol dehydrogenase compositions, alopecia treatment drugs and antibody serum stabilisers are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are anti-influenza antibody compositions and anti-interleukin-1, which are now well established in the industry.

Innovation S-curve for the pharmaceutical industry

Alopecia treatment drugs is a key innovation area in pharmaceutical

Alopecia treatment drugs are used to treat alopecia areata, an autoimmune condition in which hair is lost in patches in size of a large coin. The hair loss can occur in any hair-containing part of skin.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 180+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of alopecia treatment drugs.

Key players in alopecia treatment drugs – a disruptive innovation in the pharmaceutical industry

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to alopecia treatment drugs

Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies
AbbVie 336 Unlock company profile
Johnson & Johnson 268 Unlock company profile
Giuliani 180 Unlock company profile
Amorepacific Group 174 Unlock company profile
Caregen 126 Unlock company profile
L'Oreal 97 Unlock company profile
Galderma Research and Development 92 Unlock company profile
Berkshire Hathaway 64 Unlock company profile
Pierre Fabre Foundation 59 Unlock company profile
HDT Global 49 Unlock company profile
Igisu 45 Unlock company profile
Equillium 45 Unlock company profile
Estee Lauder Companies 44 Unlock company profile
Dr. Wolff Gruppe 43 Unlock company profile
Joventis 39 Unlock company profile
Almirall 39 Unlock company profile
Taisho Pharmaceutical Holdings 39 Unlock company profile
LG 32 Unlock company profile
Biolab Farmaceuticaa 32 Unlock company profile
Lonza Group 32 Unlock company profile
Symrise 31 Unlock company profile
Puretech Health 30 Unlock company profile
Royal DSM 29 Unlock company profile
Nogra Two 28 Unlock company profile
Unilever 27 Unlock company profile
Anagenics 27 Unlock company profile
Ashland Incorporated 26 Unlock company profile
Legacy Healthcare 25 Unlock company profile
Samson Clinical 24 Unlock company profile
Kao 24 Unlock company profile
Triple Hair 23 Unlock company profile
Phyto Tech 23 Unlock company profile
Natura & Holding 22 Unlock company profile
CIMTECH 22 Unlock company profile
Mallinckrodt 22 Unlock company profile
Biomendics 21 Unlock company profile
Lipidor 21 Unlock company profile
Nestle 21 Unlock company profile
Jina Pharmaceuticals 20 Unlock company profile
Huons Global 20 Unlock company profile
International Flavors & Fragrances 20 Unlock company profile
Broda Technologies 19 Unlock company profile
Shiseido 18 Unlock company profile
Direct Biologics 17 Unlock company profile
Prostemics 17 Unlock company profile
Croda International 17 Unlock company profile
Santen Pharmaceutical 17 Unlock company profile
AGC 17 Unlock company profile
Montefiore Medical Center 16 Unlock company profile
Histide 15 Unlock company profile

Source: GlobalData Patent Analytics

Caregen is one of the leading patent filers for alopecia treatment drugs. The company is developing synthetic peptide for the treatment of alopecia. Stemson Therapeutics is working on new approach for the treatment of alopecia using induced pluripotent stem cells (iPSCs)-derived folliculogenic cells. AbbVie Ventures invested $15m in the alopecia programme of Stemson Therapeutics.

To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Pharmaceutical.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.